Completed PHASE2 INTERVENTIONAL 1-arm NCT03666208

Sirolimus Coated Angioplasty Balloon in the Salvage of Thrombosed Arteriovenous Graft

Sponsor: Singapore General Hospital

Conditions Arteriovenous Graft Occlusion End Stage Renal Failure on Dialysis

Updated 5 times since 2018 Last updated: Sep 9, 2019 Started: Jul 1, 2018 Primary completion: Sep 2, 2019 Completion: Sep 2, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Arteriovenous Graft Occlusion and End Stage Renal Failure on Dialysis, this trial is completed. The trial is conducted by Singapore General Hospital and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Oct 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Oct 2018 — Oct 2019 [monthly]

Active Not Recruiting PHASE2

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Singapore General Hospital

Data source: Singapore General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore